Vredenburgh, J. J., Desjardins, A., Reardon, D. A., Peters, K. B., Herndon, J. E., Marcello, J., . . . Friedman, H. S. (2011). The Addition of Bevacizumab to Standard Radiation Therapy and Temozolomide Followed by Bevacizumab, Temozolomide and Irinotecan for Newly Diagnosed Glioblastoma.
Citação norma ChicagoVredenburgh, James J., et al. The Addition of Bevacizumab to Standard Radiation Therapy and Temozolomide Followed By Bevacizumab, Temozolomide and Irinotecan for Newly Diagnosed Glioblastoma. 2011.
MLA citiranjeVredenburgh, James J., et al. The Addition of Bevacizumab to Standard Radiation Therapy and Temozolomide Followed By Bevacizumab, Temozolomide and Irinotecan for Newly Diagnosed Glioblastoma. 2011.
Opozorilo: Ti citati niso vedno 100% točni.